Cargando…

Multicenter analysis of sputum microbiota in tuberculosis patients

The impact of tuberculosis and of anti-tuberculosis therapy on composition and modification of human lung microbiota has been the object of several investigations. However, no clear outcome has been presented so far and the relationship between M. tuberculosis pulmonary infection and the resident lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sala, Claudia, Benjak, Andrej, Goletti, Delia, Banu, Sayera, Mazza-Stadler, Jesica, Jaton, Katia, Busso, Philippe, Remm, Sille, Leleu, Marion, Rougemont, Jacques, Palmieri, Fabrizio, Cuzzi, Gilda, Butera, Ornella, Vanini, Valentina, Kabir, Senjuti, Rahman, S. M. Mazidur, Nicod, Laurent, Cole, Stewart T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549818/ https://www.ncbi.nlm.nih.gov/pubmed/33044973 http://dx.doi.org/10.1371/journal.pone.0240250

Ejemplares similares

Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis
por: Rahman, S. M. Mazidur, et al.
Publicado: (2018)

Diagnostic Yield of Xpert MTB/RIF Assay Using Bronchoalveolar Lavage Fluid in Detecting Mycobacterium tuberculosis among the Sputum-Scarce Suspected Pulmonary TB Patients
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2022)

Diagnostic Performance of Different Laboratory Methods for the Detection of Extrapulmonary Tuberculosis
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2023)

Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2021)

Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders
por: Delogu, Giovanni, et al.
Publicado: (2011)

Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood
por: Chiacchio, Teresa, et al.
Publicado: (2011)

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection
por: Petruccioli, Elisa, et al.
Publicado: (2018)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting
por: Opota, Onya, et al.
Publicado: (2019)

Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study
por: Simon, Andenmatten, et al.
Publicado: (2019)

Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh
por: Banu, Sayera, et al.
Publicado: (2020)

IP-10 detection in urine is associated with lung diseases
por: Cannas, Angela, et al.
Publicado: (2010)

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection
por: Chiacchio, Teresa, et al.
Publicado: (2017)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Xpert Ultra Assay on Stool to Diagnose Pulmonary Tuberculosis in Children
por: Kabir, Senjuti, et al.
Publicado: (2020)

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023)

Yield of Two Consecutive Sputum Specimens for the Effective Diagnosis of Pulmonary Tuberculosis
por: Islam, Mohammad R., et al.
Publicado: (2013)

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
por: Petrone, Linda, et al.
Publicado: (2021)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis
por: Rahman, Arfatur, et al.
Publicado: (2016)

Improvement in Tuberculosis Outcomes With a Combined Medical and Social Approach
por: Mazza-Stalder, Jesica, et al.
Publicado: (2019)

Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages
por: La Manna, Marco Pio, et al.
Publicado: (2017)

Distribution and Frequency of rpoB Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Mycobacterium tuberculosis Isolates in Bangladesh
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2020)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
por: Petrone, Linda, et al.
Publicado: (2022)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4(+) and CD8(+) T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
por: Aiello, Alessandra, et al.
Publicado: (2022)

Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh
por: Rahman, Arfatur, et al.
Publicado: (2017)

Correlation of gyr Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2021)

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
por: Najafi-Fard, Saeid, et al.
Publicado: (2022)

Critical discussion on drug efflux in Mycobacterium tuberculosis
por: Remm, Sille, et al.
Publicado: (2021)

Editorial: Tuberculosis and Non-tuberculous Mycobacteria Infections: Control, Diagnosis and Treatment
por: Opota, Onya, et al.
Publicado: (2021)

Performance of TaqMan array card to detect TB drug resistance on direct specimens
por: Banu, Sayera, et al.
Publicado: (2017)

Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2022)

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
por: Petrone, Linda, et al.
Publicado: (2021)

Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
por: Aiello, Alessandra, et al.
Publicado: (2022)

Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
por: Petrone, Linda, et al.
Publicado: (2022)

Quantitative Drug-Susceptibility in Patients Treated for Multidrug-Resistant Tuberculosis in Bangladesh: Implications for Regimen Choice
por: Heysell, Scott K., et al.
Publicado: (2015)

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response
por: Butera, Ornella, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_uarodq1p23g82lmfiuai589rm0